Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Klag

Showing results (131-140 of 201) with videos related to

Pageof 21
Sort By:
Circulation|November 27, 2002
Small apolipoprotein(a) size predicts mortality in end-stage renal disease: The CHOICE studyJ Craig Longenecker, Michael J Klag, Santica M Marcovina, et al.
Journal of the American Society of Nephrology : JASN|June 29, 2002
Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE StudyJ Craig Longenecker, Josef Coresh, Neil R Powe, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causalityL Ebony Boulware, Yongmei Liu, Nancy E Fink, et al.
Clinical Nephrology|June 9, 2004
Undertreatment of hyperlipidemia in a cohort of United States kidney dialysis patientsC S Fox, J C Longenecker, N R Powe, et al.
Journal of the American Society of Nephrology : JASN|March 7, 2000
Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRDJ Craig Longenecker, Josef Coresh, Michael J Klag, et al.
Journal of the American Geriatrics Society|April 7, 2004
Physical functioning, depression, and preferences for treatment at the end of life: the Johns Hopkins Precursors StudyJoseph B Straton, Nae-Yuh Wang, Lucy A Meoni, et al.
Archives of Internal Medicine|July 14, 1997
Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins StudyA C Gelber, M J Klag, L A Mead, et al.
Nephron. Clinical Practice|August 12, 2006
Association of clinic vascular access monitoring practices with clinical outcomes in hemodialysis patientsLaura C Plantinga, Bernard G Jaar, Brad Astor, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 5, 2001
Timing of nephrologist referral and arteriovenous access use: the CHOICE StudyB C Astor, J A Eustace, N R Powe, et al.
The New England Journal of Medicine|February 4, 1993
Serum cholesterol in young men and subsequent cardiovascular diseaseM J Klag, D E Ford, L A Mead, et al.
Pageof 21

Showing results (131-140 of 201) with videos related to

Sort By:
Pageof 21
Circulation|November 27, 2002
Small apolipoprotein(a) size predicts mortality in end-stage renal disease: The CHOICE studyJ Craig Longenecker, Michael J Klag, Santica M Marcovina, et al.
Journal of the American Society of Nephrology : JASN|June 29, 2002
Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE StudyJ Craig Longenecker, Josef Coresh, Neil R Powe, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causalityL Ebony Boulware, Yongmei Liu, Nancy E Fink, et al.
Clinical Nephrology|June 9, 2004
Undertreatment of hyperlipidemia in a cohort of United States kidney dialysis patientsC S Fox, J C Longenecker, N R Powe, et al.
Journal of the American Society of Nephrology : JASN|March 7, 2000
Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRDJ Craig Longenecker, Josef Coresh, Michael J Klag, et al.
Journal of the American Geriatrics Society|April 7, 2004
Physical functioning, depression, and preferences for treatment at the end of life: the Johns Hopkins Precursors StudyJoseph B Straton, Nae-Yuh Wang, Lucy A Meoni, et al.
Archives of Internal Medicine|July 14, 1997
Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins StudyA C Gelber, M J Klag, L A Mead, et al.
Nephron. Clinical Practice|August 12, 2006
Association of clinic vascular access monitoring practices with clinical outcomes in hemodialysis patientsLaura C Plantinga, Bernard G Jaar, Brad Astor, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 5, 2001
Timing of nephrologist referral and arteriovenous access use: the CHOICE StudyB C Astor, J A Eustace, N R Powe, et al.
The New England Journal of Medicine|February 4, 1993
Serum cholesterol in young men and subsequent cardiovascular diseaseM J Klag, D E Ford, L A Mead, et al.
Pageof 21